FULGENT GENETICS, INC. Stock-Based Compensation
FULGENT GENETICS, INC. (FLGT) reported Stock-Based Compensation of $18.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-30
- FULGENT GENETICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $8.62M, a 14.10% decline year-over-year.
- FULGENT GENETICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $9.89M, a 6.26% decline year-over-year.
- FULGENT GENETICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $9.28M, a 10.88% decline year-over-year.
- FULGENT GENETICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $9.72M, a 11.02% decline year-over-year.
- FULGENT GENETICS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $39.58M, a 11.01% decline from fiscal 2024.
- FULGENT GENETICS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $44.48M, a 3.63% increase from fiscal 2023.
- FULGENT GENETICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $42.92M, a 31.50% increase from fiscal 2022.
- FULGENT GENETICS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $32.64M, a 105.52% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $18.51M 10-Q · filed 2026-07-30 | $27.79M derived: sum of 3 quarters · filed 2026-07-30 | $37.51M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $9.89M 10-Q · filed 2026-05-01 | $19.17M derived: sum of 2 quarters · filed 2026-05-01 | $28.88M derived: sum of 3 quarters · filed 2026-05-01 | $38.92M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $9.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $18.99M derived: sum of 2 quarters · filed 2026-02-27 | $29.03M derived: sum of 3 quarters · filed 2026-07-30 | $39.58M 10-K · filed 2026-02-27 |
| 2025-09-30 | $9.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $19.76M derived: sum of 2 quarters · filed 2026-07-30 | $30.31M 10-Q · filed 2025-11-07 | $40.71M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $10.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $20.59M 10-Q · filed 2026-07-30 | $31.00M derived: sum of 3 quarters · filed 2026-07-30 | $41.92M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $10.55M 10-Q · filed 2026-05-01 | $20.96M derived: sum of 2 quarters · filed 2026-05-01 | $31.88M derived: sum of 3 quarters · filed 2026-05-01 | $43.51M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $10.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $21.33M derived: sum of 2 quarters · filed 2026-02-27 | $32.96M derived: sum of 3 quarters · filed 2026-02-27 | $44.48M 10-K · filed 2026-02-27 |
| 2024-09-30 | $10.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $22.55M derived: sum of 2 quarters · filed 2025-11-07 | $34.07M 10-Q · filed 2025-11-07 | $45.51M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $11.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $23.15M 10-Q · filed 2025-08-01 | $34.59M derived: sum of 3 quarters · filed 2026-02-27 | $45.49M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $11.52M 10-Q · filed 2025-05-02 | $22.95M derived: sum of 2 quarters · filed 2026-02-27 | $33.85M derived: sum of 3 quarters · filed 2026-02-27 | $44.17M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $11.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $22.33M derived: sum of 2 quarters · filed 2026-02-27 | $32.66M derived: sum of 3 quarters · filed 2026-02-27 | $42.92M 10-K · filed 2026-02-27 |
| 2023-09-30 | $10.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $21.23M derived: sum of 2 quarters · filed 2024-11-08 | $31.49M 10-Q · filed 2024-11-08 | $41.51M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $10.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $20.59M 10-Q · filed 2024-08-02 | $30.61M derived: sum of 3 quarters · filed 2025-02-28 | $39.58M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $10.27M 10-Q · filed 2024-05-03 | $20.29M derived: sum of 2 quarters · filed 2025-02-28 | $29.26M derived: sum of 3 quarters · filed 2025-02-28 | $37.29M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $10.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $18.99M derived: sum of 2 quarters · filed 2025-02-28 | $27.02M derived: sum of 3 quarters · filed 2025-02-28 | $32.64M 10-K · filed 2025-02-28 |
| 2022-09-30 | $8.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $17.00M derived: sum of 2 quarters · filed 2023-11-03 | $22.62M 10-Q · filed 2023-11-03 | $27.64M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $8.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $13.65M 10-Q · filed 2023-08-04 | $18.67M derived: sum of 3 quarters · filed 2024-02-28 | $23.04M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $5.62M 10-Q · filed 2023-05-05 | $10.64M derived: sum of 2 quarters · filed 2024-02-28 | $15.01M derived: sum of 3 quarters · filed 2024-02-28 | $18.54M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $5.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $9.39M derived: sum of 2 quarters · filed 2024-02-28 | $12.92M derived: sum of 3 quarters · filed 2024-02-28 | $15.88M 10-K · filed 2024-02-28 |
| 2021-09-30 | $4.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $7.90M derived: sum of 2 quarters · filed 2022-11-07 | $10.86M 10-Q · filed 2022-11-07 | $13.87M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $3.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $6.49M 10-Q · filed 2022-08-04 | $9.49M derived: sum of 3 quarters · filed 2023-02-28 | $12.64M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $2.96M 10-Q · filed 2022-05-05 | $5.96M derived: sum of 2 quarters · filed 2023-02-28 | $9.12M derived: sum of 3 quarters · filed 2023-02-28 | $10.20M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $6.15M derived: sum of 2 quarters · filed 2023-02-28 | $7.23M derived: sum of 3 quarters · filed 2023-02-28 | $8.16M 10-K · filed 2023-02-28 |
| 2020-09-30 | $3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $4.23M derived: sum of 2 quarters · filed 2021-11-09 | $5.15M 10-Q · filed 2021-11-09 | $6.09M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $2.00M 10-Q · filed 2021-08-10 | $2.94M derived: sum of 3 quarters · filed 2022-02-28 | $3.89M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $924.00K 10-Q · filed 2021-05-07 | $1.86M derived: sum of 2 quarters · filed 2022-02-28 | $2.81M derived: sum of 3 quarters · filed 2022-02-28 | $3.55M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $938.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.89M derived: sum of 2 quarters · filed 2022-02-28 | $2.63M derived: sum of 3 quarters · filed 2022-02-28 | $3.21M 10-K · filed 2022-02-28 |
| 2019-09-30 | $951.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.69M derived: sum of 2 quarters · filed 2020-11-09 | $2.27M 10-Q · filed 2020-11-09 | $2.87M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $737.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $1.32M 10-Q · filed 2020-08-05 | $1.92M derived: sum of 3 quarters · filed 2020-08-05 | $2.51M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $583.00K 10-Q · filed 2020-05-06 | $1.18M derived: sum of 2 quarters · filed 2020-05-06 | $1.77M derived: sum of 3 quarters · filed 2020-05-06 | $2.34M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $598.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $1.19M derived: sum of 2 quarters · filed 2020-03-13 | $1.76M derived: sum of 3 quarters · filed 2020-03-13 | $2.30M 10-K · filed 2020-03-13 |
| 2018-09-30 | $588.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.16M derived: sum of 2 quarters · filed 2019-11-08 | $1.71M 10-Q · filed 2019-11-08 | $2.29M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $573.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $1.12M 10-Q · filed 2019-08-12 | $1.70M derived: sum of 3 quarters · filed 2019-08-12 | $2.25M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $545.00K 10-Q · filed 2019-05-10 | $1.13M derived: sum of 2 quarters · filed 2019-05-10 | $1.68M derived: sum of 3 quarters · filed 2019-05-10 | $2.10M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $581.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $1.13M derived: sum of 2 quarters · filed 2019-03-22 | $1.55M derived: sum of 3 quarters · filed 2019-03-22 | $2.12M 10-K · filed 2019-03-22 |
| 2017-09-30 | $549.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $973.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.54M 10-Q · filed 2018-11-09 | $2.07M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $424.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $989.00K 10-Q · filed 2018-08-13 | $1.52M derived: sum of 3 quarters · filed 2018-08-13 | $4.02M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $565.00K 10-Q · filed 2018-05-14 | $1.10M derived: sum of 2 quarters · filed 2018-05-14 | $3.59M derived: sum of 3 quarters · filed 2018-05-14 | $3.59M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $3.03M derived: sum of 2 quarters · filed 2018-03-20 | $3.03M derived: sum of 3 quarters · filed 2018-03-20 | $4.65M 10-K · filed 2018-03-20 |
| 2016-09-30 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $2.49M derived: sum of 2 quarters · filed 2017-11-13 | $4.12M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $1.63M 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | $1.63M 10-Q · filed 2017-05-09 | |||
| 2015-12-31 | $8.16M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |